Iontophoretic contact lens

• US 9,937,074 B2
• Filed: 01/22/2016
• Issued: 04/10/2018
• Est. Priority Date: 01/22/2015
• Status: Active Grant

• Current Assignee: Eyegate Pharmaceuticals, Inc.
• Original Assignee: Eyegate Pharmaceuticals, Inc.
• Inventors: Manzo, Michael
• Primary Examiner(s): FLICK, JASON E
• Application Number:
  US15/004,867
• Publication Number:
  US 20160213514A1
• Time in Patent Office: 809 Days
• Field of Search: 604 20
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 9/0009 involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis microelectromechanical systems A61K9/0097
• CPC Class Codes: A61K 9/0048 Eye, e.g. artificial tears
• CPC Class Codes: A61N 1/0428 Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
• CPC Class Codes: A61N 1/044 Shape of the electrode
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: G02C 7/04 Contact lenses for the eyes disinfection or sterilisation of contact lenses A61L12/00

Abstract

Contact lenses are provided for ocular iontophoretic therapy. Implementations include a reservoir adapted to contain a charged therapeutic compound, a current source providing iontophoretic current to the charged therapeutic composition to affect delivery of the charged therapeutic composition into an eyeball, and a sensing circuit controlling the current source to maintain a selected pH range of the charged therapeutic composition. Alternate embodiments include active, sacrificial electrodes for generating ions sufficient to provide electromotive repulsive force to the charged compound to effect transport into ocular tissue.

Claims

1. A contact lens for ocular therapy, comprising:

a reservoir containing a charged therapeutic composition;

a current source providing iontophoretic current to the charged therapeutic composition to affect delivery of the charged therapeutic composition into an eyeball;

a sensing circuit controlling the current source to maintain a selected pH range of the charged therapeutic composition; and

a polarity selective barrier region disposed at a perimeter of the reservoir and having a polarity the same as that of the charged composition in the corresponding reservoir.

2. The contact lens of claim 1, further comprising at least one of the following components:

a buffer layer adapted to maintain a selected pH range of the charged therapeutic composition within the reservoir;

a first conductive layer adapted to distribute the iontophoretic current to at least one of the reservoir and a buffer layer; and

a first conductive layer including the current source and a second conductive layer having a higher resistivity than the first conductive layer, the second conductive layer adapted to evenly distribute current to at least one of the reservoir and a buffer layer.

3. The contact lens of claim 2 further comprising a center portion to which the reservoir and the layer component(s) are annularly mounted.

4. The contact lens of claim 3, wherein the center portion has a surface conforming to a cornea surface.

5. The contact lens of claim 3, wherein the charged therapeutic composition, the current source and the sensing circuit are located outside of the center portion.

6. The contact lens of claim 1, comprising a layer having a surface conforming to a surface of an eyeball.

7. The contact lens of claim 1, wherein the current source comprises a power converter for receiving energy from an external source and converting the energy to the iontophoretic current.

9. The contact lens of claim 1, wherein the current source comprises a converter configured to convert power wirelessly received from an external source.

10. The contact lens of claim 1, wherein the current source comprises at least one of an energy storage component and energy harvesting circuitry.

8. A contact lens for ocular therapy, comprising:

a reservoir containing a charged therapeutic composition;

a current source providing iontophoretic current to the charred therapeutic composition to affect delivery of the charred therapeutic composition into an eyeball; and

a sensing circuit controlling the current source to maintain a selected pH range of the charged therapeutic composition,

wherein the sensing circuit comprises;

a pH sensor configured to detect the pH level of the charge therapeutic composition; and

a current source controller configured to change the iontophoretic current when the detected pH level is outside the selected pH range

a polarity selective barrier region disposed at a perimeter of the reservoir having a polarity the same as that of the charged composition in the corresponding reservoir.

11. A contact lens for ocular therapy, comprising:

a reservoir adapted to contain a charged therapeutic compound;

a sacrificial electrode with a sacrificial element in contact with the charged therapeutic compound, the sacrificial electrode adapted to generate ions having the same charge polarity as the charged therapeutic compound through consuming the sacrificial element;

a voltage source providing iontophoretic voltage to the sacrificial electrode to affect an electric motive force causing delivery of the charged therapeutic compound into an eyeball; and

a sensing circuit controlling the voltage source to adjust the delivery of the charged therapeutic compound.

12. The contact lens of claim 11 wherein:

the sensing circuit comprises

a sensor configured to detect the conductivity of the sacrificial electrode, and

a voltage source controller configured to change the iontophoretic voltage when the detected sacrificial electrode conductivity is outside a selected range.